Boston Scientific, Angiotech suffer downgrades over drug-coated stents

NEW YORK (AP) - Boston Scientific Corp., maker of the Taxus drug-coated heart stent, and specialty drug supplier Angiotech Pharmaceuticals Inc. both suffered downgrades at the hands of investment firm Merrill Lynch as more competitors enter the drug-coated stent field....More